You are here

NEW DRUGS FOR THE TREATMENT OF BREAST CANCER

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 1R43CA080472-01
Amount: $100,378.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1999
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
533 GREAT ARROW AVE
BUFFALO, NY 14207
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 JOSEPH DUNN
 () -
Business Contact
Phone: (716) 636-5107
Email: JDUNN @BUFFALO.COM
Research Institution
N/A
Abstract

Not Available The dispersal of special nuclear material (SNM) from US nuclear weapons has been given high level attention from the executive and legislative branches of government since the early 1990s. The studies and assessments to date have focused on abnormal environments initiated by accidents during normal peacetime military operations. These studies have identified some abnormal environments in which disposal is likely to occur. These environments can be initiated by accident or intentionally by terrorists. Dispersal by intentional means is likely to have the same health and political consequences with respect to public consequences as dispersal by accidental means. Phase I research will develop a methodology to assess intentional actions such that the quantified risk of these actions is comparable with the risk quantified by accepted methods for accidents. The specific objectives are to assess the likelihood and effectiveness of a terrorist attack and support their integration into DTRA's Nuclear Weapon System Safety Assessment.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government